T-cell acute lymphoblastic leukemia

The FDA has granted Fast Track Designation and Rare Pediatric Disease Designation for WU-CART-007.

Leah LawrenceT-Cell Lymphoma | April 4, 2022

WU-CART-007 is being tested as part of a phase 1/2 trial that will evaluate if use of the off-the-shelf therapy is safe and ...

Editorial Board

Sagar Lonial, MD, FACPSagar Lonial, MD, FACP, of the Winship Cancer Institute, is Editor-in-Chief of Blood Cancers Today.

Elias Jabbour, MDAssociate Editor | Professor in the Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center

Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center

Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch

Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer